Drug
Emtricitabine/Rilpivirine/Tenofovir Alafenamide Fumarate clinical trials
How studies write it
Studies that test it under each name
Studies by the year they started
4 studies that test it; most in 2015 (2)
| Year | Studies |
|---|---|
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 1
Often tested with
Tested in the same studies.
Elvitegravir (2) · Cobicistat (2) · Emtricitabine (2) · Tenofovir alafenamide (2)
Studies
Open first, then newest update. How each study uses Emtricitabine/Rilpivirine/Tenofovir Alafenamide Fumarate is read from its arms, and is right about nine times in ten.
Testing it · 4
- Study to Evaluate Switching From a Regimen Consisting of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate (EFV/FTC/TDF) Fixed Dose Combination (FDC) to Emtricitabine/Rilpivirine/Tenofovir Alafenamide (FTC/RPV/TAF) FDC in Virologically-Suppressed, HIV-1 Infected AdultsCompletedPhase 3Gilead SciencesNCT02345226Written as FTC/RPV/TAF
- Switch Study to Evaluate the Safety and Efficacy of Emtricitabine/Rilpivirine/Tenofovir Alafenamide (FTC/RPV/TAF) Fixed Dose Combination (FDC) in HIV-1 Positive Adults Who Are Virologically Suppressed on Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate (FTC/RPV/TDF)CompletedPhase 3Gilead SciencesNCT02345252Written as FTC/RPV/TAF
- Efficacy, Safety, and Tolerability of Ledipasvir/Sofosbuvir (LDV/SOF) Treatment for HIV/HCV Co-infected Participants Who Switch to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) or Emtricitabine/Rilpivirine/Tenofovir Alafenamide (F/R/TAF) Prior to LDV/SOF HCV TreatmentCompletedPhase 3Gilead SciencesNCT02707601Written as F/R/TAF
- Changes in Insulin Sensitivity in Healthy Volunteers Taking Tenofovir Alafenamide (TAF)-Containing Antiretroviral MedicationCompletedPhase 1Technical University of MunichNCT03092206Written as R/F/TAF